That mutation, according to the Stanford Cancer Center, increases a woman's risk of breast cancer to 65% and ovarian cancer to 39% by the age of 70. Justices at odds over patents for human genes Myriad's test is targeted at people at high risk. a blood test that has helped thousands of women find out their risk for hereditary breast and ovarian cancer. Women's voices created the campaign message: "Breast cancer runs in my family. In this spirit, the American College of Medical Genetics explains that gene patents, to the contrary, limit innovation and accessibility, hinder quality, slow improvement and restrict the workforce.